CYAD
Celyad Oncology SA American Depositary Shares
CYAD
CYAD
Delisted
CYAD was delisted on the 18th of May, 2023.
6 hedge funds and large institutions have $6.8M invested in Celyad Oncology SA American Depositary Shares in 2016 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
6
Holders Change
-1
Holders Change %
-14.29%
% of All Funds
0.15%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
3
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Victory Capital Management
San Antonio,
Texas
|
+$10.4K |
| 2 |
Morgan Stanley
New York
|
+$8.52K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$1K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$585 |
Top Sellers
| 1 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$1.79M |
| 2 |
Zurich Cantonal Bank
Zurich,
Switzerland
|
-$133K |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$2K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Victory Capital Management
San Antonio,
Texas
| $6.33M | +$10.4K | +580 | +0.2% |
|
|
DCM
2
DAFNA Capital Management
Los Angeles,
California
| $222K | – | – | – |
|
|
3
Zurich Cantonal Bank
Zurich,
Switzerland
| $187K | -$133K | -7,368 | -41% |
|
|
4
Morgan Stanley
New York
| $46K | +$8.52K | +480 | +23% |
|
|
TRCT
5
Tower Research Capital (TRC)
New York
| $7K | +$585 | +29 | +9% |
|
|
6
UBS Group
Zurich,
Switzerland
| $1K | +$1K | +64 | New |
|
|
CAM
7
Cormorant Asset Management
Boston,
Massachusetts
| – | -$1.79M | -75,920 | Closed |
|
|
8
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$2K | -70 | Closed |
|